Find Academic Supervisors

ALEJANDRO ESPI MACIAS is a Professor in the Department of Surgery at Universitat de València, where he is actively involved in research related to solid tumors and surgical immunology. He is a member of the InDeST Research Group (Innovative Diagnostic and Therapeutical Developments in Solid Tumors), focusing on advancing diagnostic and therapeutic strategies for cancer patients. His research interests lie at the intersection of surgery and immunology, particularly in how surgical intervention affects the immune system. Key areas include the role of immunoglobulins (G, A, M) and the complement system in response to surgical trauma, with implications for postoperative immunity and cancer progression. His work supports the development of innovative clinical approaches in oncological surgery. The trends in his research, though not detailed in publications here, suggest a long-standing focus on the immunological consequences of surgery, especially in cancer contexts. This foundational work contributes to personalized surgical strategies and improved patient outcomes in solid tumor management. Member, InDeST Research Group – Innovative Diagnostic and Therapeutical Developments in Solid Tumors He completed his doctoral studies at Universitat de València in 1984, with a thesis titled "Efecto de la agresión quirúrgica sobre las inmunoglobulinas (G.A.M.) y sistema del complemento", supervised by Dr. Juan García de Lomas Barrionuevo. While no formal advisees or grants are listed, his academic leadership as a Titular Professor indicates significant contributions to surgical science and mentorship within his department. His work is centered within the InDeST research group, which aims to bridge diagnostic innovation with therapeutic advancement in solid tumor oncology, integrating clinical surgery with immunological monitoring and response assessment.

• Surgical Oncology
• Immunology in Solid Tumors
• Cancer Diagnostics
• +5 more

Xavier Trepat is an ICREA Research Professor and Group Leader at the Institute for Bioengineering of Catalonia (IBEC), affiliated with the University of Barcelona. His academic journey includes a BSc in Physics (2000), a BSc in Engineering (2001), and a PhD in Medical Sciences (2004) from the University of Barcelona. He conducted postdoctoral research at Harvard University and later held positions at the University of Barcelona and IBEC, becoming an ICREA Research Professor in 2011. His research focuses on mechanobiology, integrating physics and biology to study cellular and tissue dynamics. Key areas include cytoskeletal mechanics, collective cell migration, cancer metastasis, and organoid engineering. He has pioneered techniques like traction force microscopy and microfluidic platforms (e.g., MIRO chip) to model tumor-stroma interactions. Recent work highlights include uncovering mechanical signaling pathways (YAP/TAZ-TEAD), the role of nuclear mechanics in cancer, and the development of 3D tissue models. His studies on durotaxis and collective cell migration have advanced understanding of how cells sense and respond to mechanical cues. Collaborations span institutions like Harvard, MIT, and leading research centers globally.

• Mechanobiology
• Cellular Biophysics
• Cancer Biology
• +3 more

Tania Fernández Villa is an Associate Professor in the Department of Biomedical Sciences at the Faculty of Veterinary Medicine, University of León. Her primary academic affiliation centers on preventive medicine and public health research within the GIIGAS (Interactions Gene-Environment-Health) research group. Her research spans nutritional epidemiology, gender studies in food systems, substance use disorders, and chronic disease prevention. Key focus areas include alcohol consumption patterns among university students (via the UniHcos cohort), sarcopenia in metabolic syndrome, breast cancer risk factors, and pandemic impacts on health behaviors. Her work integrates longitudinal cohort analysis, systematic reviews, and psychometric validation studies. Recent publications demonstrate strong trends in gender-disaggregated health research, pandemic-related behavioral shifts, and methodological innovations in dietary assessment. Her 2024-2025 output shows increasing emphasis on environmental sustainability of diets and multi-cancer risk prediction models. She serves on the editorial board of the Spanish Journal of Human Nutrition and Dietetics, contributing to strategic planning (2020-2026) and open science initiatives. Her PhD from Universidad de Granada focused on ICT usage patterns among university students. Current projects include the UniHcos longitudinal study tracking health behaviors in Spanish university students, with particular attention to alcohol use, sleep patterns, and nutritional status. Her research group actively investigates gene-environment interactions in public health contexts.

• Preventive Medicine
• Public Health
• Nutritional Epidemiology
• +5 more

Marcos García Fuentes is a Professor at the Department of Pharmacology, Pharmacy and Pharmaceutical Technology, University of Santiago de Compostela (USC), Spain. He leads the NANOBIOFAR research group focused on nanotechnologies for drug delivery systems and is affiliated with the Center for Research in Molecular Medicine and Chronic Diseases (CIMUS). His expertise includes pharmaceutical biomaterials, cancer therapy, and gene delivery. He earned his PhD in 2004 from USC with a thesis on lipid nanoparticles for peptide transport, supervised by Dr. María José Alonso Fernández and Dr. Dolores Torres López. His research interests revolve around nanomedicine, particularly in designing drug delivery systems using polyphosphazenes, viral protein nanoparticles, and mRNA-activated matrices. He explores applications in glioblastoma treatment, cancer immunotherapy, and regenerative medicine. His work bridges biomaterials science with pharmaceutical innovation, addressing challenges in targeted drug delivery and controlled release systems. Recent publications highlight advancements in gene therapy via polyphosphazene derivatives, protamine-based nanotherapeutics, and self-assembled peptide-polymer hybrids. His contributions span oncology, immunology, and tissue engineering, with a focus on translating nanotechnologies into clinical applications. No scientific awards are explicitly mentioned, but his prolific publication record underscores his impact in the field. He advises research in biomaterials and drug delivery systems through CIMUS and the NANOBIOFAR group. His lab develops platforms for cancer treatment, stem cell differentiation, and chronic disease management. Collaborations include multidisciplinary projects in biomaterial design, pharmaceutical formulation, and nanomedicine.

• Nanomedicine
• Drug Delivery Systems
• Pharmaceutical Technology
• +3 more

Albert Gibert Bosch serves as an Assistant Professor in the Department of Organic and Pharmaceutical Chemistry at IQS School of Engineering, Universitat Ramon Llull. He is an active member of the Pharmaceutical Chemistry Group (GQF) and has been involved in significant research projects spanning from 2014 to 2025. His research spans multiple areas of pharmaceutical chemistry with a focus on drug discovery and development. Key research interests include molecular modeling for drug design, CXCR4 inhibitors for cancer treatment, HIV therapeutics, nanoparticle drug delivery systems, and tyrosine kinase inhibitors. His work demonstrates strong interdisciplinary connections between computational chemistry, medicinal chemistry, and cancer biology. Recent publication trends show a consistent focus on CXCR4 targeting compounds with applications in both oncology (particularly B-cell lymphoma) and HIV treatment. His research utilizes advanced molecular modeling techniques to design novel compounds with therapeutic potential. Dr. Bosch has participated in multiple research projects including DisX4lymph: Design and synthesis of CXCR4 allosteric inhibitors and IRAK4 degraders as potential treatments of B-cell lymphoma (2022-2025), and has been part of the Pharmaceutical Chemistry Group funded by Agència de Gestió d'Ajuts Universitaris i de Recerca (AGAUR) from 2022-2025.

• Bioactivity
• Mesoporous Silica
• Tyrosine Kinase Inhibitor
• +6 more

Marco Celentani is an Associate Professor at Universidad Carlos III de Madrid and currently serves as Director of the PhD School. He holds a Ph.D. in Economics from the University of California, Los Angeles (UCLA). His research focuses on Game Theory, Reputation, Law, Contract Theory, Corporate Governance, and Political Economy, with recent emphasis on economic voting, trust dynamics, debtor protection, and legal aid. Key contributions include analyses of bankruptcy regimes, executive compensation mechanisms, corruption dynamics in public procurement, and inflation in open economies. His work bridges theoretical frameworks with applied policy analysis, particularly in legal and institutional contexts. Celentani has published extensively in top journals like Economic Theory , Review of Economic Dynamics , and European Economic Review . His research often addresses real-world challenges in market efficiency, institutional design, and public policy.

• Game Theory
• Reputation
• Law
• +7 more

Maria Cristina Marinescu is a Professor in the Department of Mathematics and Data Analytics at IQS School of Engineering , with a focus on Applied Data Analytics and Modeling . She has an active research profile in interdisciplinary domains connecting computational methods with public health, social sciences, and medical applications.

• Applied Data Analytics
• Machine Learning
• Computational Modeling
• +4 more

Eduard Bardají Rodríguez is a Professor in the Department of Chemistry at the University of Girona, where he has been active since 1992. He is affiliated with the Institute of Agro-Food Technology and leads the LIPPSO research group (Laboratory for Innovation in Organic Synthesis Processes and Products), recognized as a Consolidated Research Group by the Generalitat de Catalunya. His work bridges organic chemistry, biomedicine, and agro-food innovation through the design and application of bioactive peptides. Research Interests: His primary focus lies in the discovery and development of bioactive peptides with applications in antimicrobial, anticancer, analgesic, neuroprotective, and cardiovascular therapies. His work integrates synthetic organic chemistry with biological evaluation, aiming to translate basic findings into practical solutions in medicine and agriculture. The recent publication trends highlight a strong emphasis on peptide-based drug discovery, particularly targeting pain, neurodegeneration, and infectious diseases. His research extends into plant biotechnology (e.g., expressing antimicrobial peptides in rice) and combating citrus diseases (HLB), demonstrating a multidisciplinary approach spanning human health and sustainable agriculture. Scientific Awards and Recognition: Consolidated Research Group status for LIPPSO by the Generalitat de Catalunya Advising and Grants: He has led and participated in numerous competitive research projects, including MINECO, PLANT-KBBE (Trilateral Project), IAPP PEP2BRAIN, and H2020 PreHLB. He has established industrial collaborations with companies such as Medichem, Croda, and Menadione. He co-founded the spin-off AMPbiotech to commercialize antimicrobial technologies, reflecting a strong commitment to technology transfer and innovation. Laboratories and Teams: He leads the LIPPSO research group and maintains a strategic alliance with the CIDSAV group, fostering collaborative research in applied antimicrobial development.

• Organic Chemistry
• Bioactive Peptides
• Antimicrobial Development
• +7 more

Dr. Le Lu serves as Researcher & Senior Director leading global Medical AI R&D efforts at Alibaba DAMO Academy since August 2021. His career spans prestigious institutions including the National Institutes of Health, Clinical Center, Radiology and Imaging Science Department, NVIDIA AI-Infra division, and Siemens corporate research where he was a senior staff scientist from 2006 until 2013. Ph.D. in Computer Science from Johns Hopkins University (2007) Dr. Lu specializes in medical imaging AI with significant contributions to oncology imaging and computer vision applications in healthcare. His research bridges advanced AI techniques with clinical applications, particularly in cancer screening and diagnostic imaging. He has published over 250 peer-reviewed articles in top-tier journals including Nature Medicine, Nature Communications, and IEEE Transactions on Pattern Analysis and Machine Intelligence, with more than 23,880 citations as of January 2024. Dr. Lu has received numerous accolades including IEEE Fellowship and recognition for publishing the most cited papers in IEEE TMI and CVPR medical imaging categories over the past decade. His innovative work has resulted in over 100 patent filings across multiple jurisdictions. IEEE Fellow (Computer Society) for contributions to medical imaging, AI and oncology imaging IEEE Signal Processing Society Distinguished Industrial Speaker (2021-2023) Associate Editor for IEEE Trans. Pattern Analysis and Machine Intelligence (IF: 24.3) Associate Editor for IEEE Signal Processing Letters and Frontiers in Oncology MICCAI society board member Through his leadership at Alibaba DAMO Academy, Dr. Lu directs research initiatives focused on making AI-driven healthcare solutions accessible globally, with recent presentations on 'AI for Health for All' and cancer screening paradigms.

• Medical Imaging
• Artificial Intelligence
• Oncology Imaging
• +3 more

Domingo Savio Rodríguez Baena is a Professor at Pablo de Olavide University, affiliated with the Department of Computer Languages and Systems. His research focuses on data mining, bioinformatics, and computational biology, with a particular emphasis on biclustering algorithms, gene co-expression networks, and high-performance computing applications. PhD in Engineering, Data Science, and Bioinformatics (2012) from Pablo de Olavide University His work spans interdisciplinary domains, including recommender systems , livestock behavior analysis , and biological data interpretation . Recent articles highlight his contributions to multi-GPU optimization , ensemble learning , and historical database construction . Key collaborations include the DATAi Intelligent Data Analysis and DASE Data Analytics Science & Engineering research groups. He has developed tools like the CyEnGNet–App for gene network visualization and BIGO for gene enrichment analysis. Contact: dsrodbae@upo.es

• Data Mining
• Bioinformatics
• Machine Learning
• +3 more

Mohamed H. Doweidar is a Full Professor in the Mechanical Engineering Department at the University of Zaragoza, Spain. He is affiliated with the School of Engineering and Architecture (EINA), the Bioengineering Division of the Aragón Institute of Engineering Research (I3A), and the CIBER-BBN (Bioengineering, Biomaterials, and Nanomedicine). His academic career spans over three decades, with teaching roles since 1994 and significant contributions to computational biomechanics and biomedical engineering. Education: Ph.D. in Computational Fluid Mechanics (2004), University of Zaragoza M.Sc. in Engineering Mathematics (2001), Ain Shams University Bachelor's in Statistics & Computer Science (1997), Mansoura University Industrial Engineering Degree (1993), Benha Higher Institute of Technology Research Interests: Focus on Computational Biomechanics , Cell Simulation , Hyperelastic Materials , Finite Element Method , and Error Estimation . His work integrates computational models to study cellular behavior, tissue regeneration, and biomedical applications. Key Contributions: Authored/co-authored books on biomechanics and computational modeling, including "Digital Human Modeling and Medicine: The Digital Twin" (2022). Supervised numerous doctoral students, some of whom received university awards. Active in editorial boards, project evaluations (ANEP), and international conferences. Labs & Groups: Member of the Applied Mechanics and Bioengineering Group (AMB), CIBER-BBN, and I3A. Research spans cell migration , biomaterials , and computational oncology .

• Computational Biomechanics
• Cell Simulation
• Hyperelastic Materials
• +7 more

Dr. Antonio González Martín is a researcher in the Department of Oncology at the Faculty of Medicine, University of Navarra. He is affiliated with the University of Navarra Clinic (CUN) and the Cancer Center Clínica Universidad de Navarra (CCUN), contributing to translational oncology research through the ONCTRAS group. Education: PhD from Francisco de Vitoria University (2018), thesis: "Molecular selection of targeted therapy in the treatment of ovarian cancer with early relapse." Research Interests: Specializing in molecular-driven targeted therapies for relapsed ovarian cancers Focus on platinum-resistant ovarian cancer treatment Translational oncology applications Molecular profiling for treatment optimization Contact: Email: agonzalezma@unav.es

• Oncology
• Targeted Therapy
• Ovarian Cancer
• +3 more

Juan José Lasarte Sagastibelza is a Full Professor of Immunology at the University of Navarra, affiliated with the School of Medicine and the Department of Internal Medicine. He serves as a Principal Investigator in the Immunomodulation and Tumor Microenvironment group at Cima Universidad de Navarra, while also contributing to the Cancer Center Clínica Universidad de Navarra. PhD in Sciences, University of Navarra (1992) Bachelor in Biological Sciences, University of Navarra (1988) Research Interests: His work focuses on immunology and the development of antiviral/antitumor immunotherapies. Key areas include: Characterization of mechanisms inducing cellular/humoral immune responses Development of synthetic peptides as biological process inhibitors Study of tumor immune evasion and regulatory T cell function CAR-T cell therapies and EDA vaccination platform (licensed to Formune Vaccines) Scientific Contributions: He has co-invented 20 patents, including p144 (anti-TGF-beta peptide for systemic sclerosis clinical trial), and developed CD25-targeted nanoliposomes for tumor regression. His research spans EU Horizon 2020, Carlos III Health Institute, and private-industry collaborations (e.g., Hoffman-La Roche). Teaching & Leadership: He has supervised 15 PhD theses (5 awarded Extraordinary Doctorate) and authored 6 books. Active in academic leadership as co-director of the Immunology and Immunotherapy Program and coordinator of the Spanish Network of Cancer Immunotherapy (REINCA).

• Immunology
• Antitumor Immunotherapy
• Antiviral Immunotherapy
• +4 more

Jesús San Miguel is a Full Professor of Hematology at the University of Navarra, specializing in Hematology and Hemotherapy. He works at both the University of Navarra Clinic's Pamplona and Madrid Headquarters, contributing to its Cancer Center and other affiliated institutions. Education: Graduated in Medicine from the University of Navarra (1976) Doctor of Medicine from the University of Salamanca (specialist in Hematology, 1980) Research Interests: Multiple myeloma Minimal residual disease Development of new antitumor drugs Scientific Awards: Jan Gosta Waldenström Award (2022) Gregorio Marañón National Prize in Medicine (2021) Academy Bob Pinedo Cancer Care Award (2020) Michaeli Award for Myeloma research (2018) King Jaime I Award for Medical Research (2013) Severo Ochoa Award for Biomedical Research (2009) Editorial Roles: Associate Editor for journals including Blood , Hematologica , and Critical Reviews in Oncology/Hematology . He also serves as a reviewer for top-tier journals like New England Journal of Medicine and Lancet . Scientific Leadership: Participated in over 50 national, 5 European, and 2 American research projects, leading 35 clinical trials as principal investigator. He is affiliated with organizations such as the International Myeloma Research Foundation and serves on advisory boards for pharmaceutical companies like Janssen and Novartis.

• Hematology
• Oncology
• Biomedical Research
• +3 more

Maria Jose Soler Sempere serves as a Part-time Lecturer in the Department of Clinical Medicine at Miguel Hernandez University of Elche, specializing in Pulmonary Diseases within the Health Sciences category. Her teaching portfolio encompasses laboratory instruction for Integrated Workshops III, Internal Medicine Rotations I/II, and Respiratory System Pathology in the Medicine Bachelor's program, alongside General Pathology for Podiatry students. Her research concentrates on clinical pulmonology with emphases on COPD pathophysiology, asthma management complexities, pleural disease diagnostics, and pandemic-related respiratory impacts. Key investigations explore treatment adherence barriers including nocebo effects in inhaler therapy, novel biomarkers for effusion differentiation, and microplastic exposure from tobacco combustion. Publication trends reveal consistent clinical focus with evolving pandemic-era priorities: pre-2020 work centered on tuberculosis diagnostics and pleural biomarkers (C-reactive protein, cystatin C), while recent studies analyze COPD/asthma interactions with SARS-CoV-2, sarcopenia in exacerbations, and home management of pleural catheters. Her methodology favors observational clinical studies with biochemical and epidemiological analyses.

• Pulmonology
• Respiratory Medicine
• Internal Medicine
• +2 more